Make Genomic
Evidence Actionable
Simplify complex genetic data into actionable insights for patient diagnosis and precision medicine development with Genomenon's software, data, and services.
Navigating Genomic Data
Genomic data is growing rapidly, but finding clinically relevant insights remains difficult. The complexity and inconsistency across resources slow down diagnosis and limit the potential of precision medicine.
Genomenon solves this by organizing the world’s genomic knowledge into powerful platforms that connect clinicians, researchers and precision therapeutic developers with the most relevant evidence. Through our advanced AI technology and team of scientific experts, we are unlocking previously buried genomic data in clinical literature into actionable insights.
What We Offer
Software
Explore Genomenon's platforms for germline and somatic variant interpretation
Mastermind Genomic Intelligence Platform
Access actionable insights from genomic literature on more than 27 million variants, as well as curated germline variant content to aid clinical decision making.
Cancer Knowledgebase (CKB)
Genomenon's Cancer Knowledgebase is used to interpret cancer variants, connecting them to therapies and clinical trials.
Services
Genomenon's expert team of genetic scientists provides tailored consulting services to support your genomic projects. From custom variant analysis to clinical trial support and regulatory guidance, we ensure you have the expert insights needed for your specific genomic challenges.
Data
Gain access to Genomenon's expansive, constantly updated database of curated genomic information. This resource offers a wealth of gene-disease associations and variant data, whether indexed or curated, delivered via an API or flat files for direct integration into your tertiary analytic platform.
Trusted by Industry Leaders Including
Driving Insights and Discovery across Clinical Diagnostics and Precision Therapeutics
Never Miss a
Diagnosis
Genomenon accelerates variant interpretation and increases your diagnostic yield with rapid genomic literature search and comprehensive genomic insights.
Inform Your Drug Program
Partner with Genomenon to gain rapid, real-world evidence insights that de-risk your precision medicine program from discovery to commercialization, supporting your genetic research.
"Genomenon’s innovative approach to leveraging literature for real-world evidence significantly enhanced our understanding of ENPP1 Deficiency."
"By partnering with Genomenon, we are helping to close critical knowledge gaps, accelerate accurate diagnosis, and support the global research community in their efforts to bring hope and new possibilities to those affected by TK2d."
"CKB enables comprehensive and reliable interpretation of any genomic test in a fully automated setting. We can rely on never missing relevant variants."
Catherine Nester
Senior Vice President, HCP and Patient Engagement at Inozyme Pharma
Sarah Chang, Ph.D.
Medical Strategy Lead at UCB
Korneel Duyvesteyn
Development lead at Hartwig Medical Foundation
Helping to Make an Impact
Driving Diagnostic Confidence - Unlock the Full Potential of Mastermind
IN THIS SESSION, YOU WILL LEARN ABOUT:
- Powerful, advanced insights available with a Mastermind PRO subscription
- The most requested features from users like you
- Tips to maximize value across your workflows
Developing Treatments for Rare Disease
YOU WILL GAIN RARE INSIGHTS INTO:
- How rare disease companies decide which orphan drug programs to pursue
- How to foster stronger collaboration among drug developers, KOLs, patient advocates, and other stakeholders
- How we can work together to help end the diagnostic odyssey for rare disease patients
- A vision for the future of orphan drug development and patient advocacy
The End of VUS? Impact on Diagnosis and Treatment of Rare Diseases
WE WILL DISCUSS:
- The impact of VUS on diagnosis and treatment
- Current and future strategies to reduce the burden of VUS
- The likelihood of eliminating VUS and what it would mean if we did
- A vision for the future of rare disease diagnostics
Medium length heading goes here
Medium length heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Medium length heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Medium length heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
